Research
Trump Officials Will Fund New Research on Controversial Psychedelic Drug Ibogaine
The Brief
- Federal officials announced new funding on Thursday to explore the medical potential of ibogaine, a controversial psychedelic drug.
- Ibogaine has been championed by veterans, conservative lawmakers, and podcasters aligned with President Donald Trump.
- The source article is from MedPage Today, a medical news outlet for physicians.
Why it matters
Federal funding for ibogaine research could generate new clinical evidence on a psychedelic compound whose medical value and safety are still contested.
Who’s affected
- clinicians and researchers interested in psychedelic medicine
- veterans and patients seeking treatments for addiction or mental health conditions
- policymakers following federal drug research funding
- #ibogaine
- #psychedelics
- #drug research
- #federal funding
- #veterans health
(MedPage Today) -- Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug championed by veterans, conservative lawmakers, and podcasters aligned with President Donald Trump...
Timeline
Federal officials announced new funding to explore the medical potential of ibogaine
MedPageToday.com - medical news for physicians
Trump Officials Will Fund New Research on Controversial Psychedelic Drug Ibogaine